KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $558,486 | +56.2% | 52,787 | +80.5% | 0.26% | -12.0% |
| Q1 2023 | $357,630 | -82.4% | 29,242 | -82.2% | 0.29% | -75.9% |
| Q4 2022 | $2,036,642 | -24.7% | 164,113 | -17.1% | 1.21% | -21.8% |
| Q3 2022 | $2,706,000 | -32.2% | 198,076 | -9.1% | 1.55% | -35.9% |
| Q2 2022 | $3,994,000 | +68.0% | 217,895 | +47.4% | 2.41% | +59.6% |
| Q1 2022 | $2,377,000 | +106.7% | 147,833 | +80.0% | 1.51% | +65.0% |
| Q4 2021 | $1,150,000 | -13.4% | 82,124 | +15.9% | 0.92% | +4.2% |
| Q3 2021 | $1,328,000 | +65.8% | 70,888 | +84.5% | 0.88% | +54.8% |
| Q2 2021 | $801,000 | -6.2% | 38,428 | +27.2% | 0.57% | -10.6% |
| Q1 2021 | $854,000 | +5.8% | 30,212 | +22.3% | 0.64% | +23.3% |
| Q4 2020 | $807,000 | +6.0% | 24,708 | -0.5% | 0.52% | -7.2% |
| Q3 2020 | $761,000 | +56.9% | 24,833 | -16.5% | 0.56% | +38.1% |
| Q2 2020 | $485,000 | – | 29,741 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |